Angiopoietin-like 3 Inhibitors [MoA] - N0000193916

Pharmacologic Class Information

Pharmacologic Code N0000193916
Pharmacologic Name Angiopoietin-like 3 Inhibitors
Pharmacologic Uses
  • ANGPTL3 (angiopoietin-like 3) inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Angiopoietin-like 3 Inhibitors

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Angiopoietin-like 3 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
61755-010Evkeeza Non-Proprietary Name: EvinacumabInjection, Solution, ConcentrateIntravenousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-013Evkeeza Non-Proprietary Name: EvinacumabInjection, Solution, ConcentrateIntravenousRegeneron Pharmaceuticals, Inc.ACTIVE